Catalyst Wire Dossier Catalyst Wire Dossier

Fluticasone furoate/umeclidinium

fluticasone furoate/umeclidinium · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fluticasone furoate/umeclidinium, covering 2017-06-09 to 2017-06-09. Get the full timeline:

Most recent: Clinical Trial Update: To Investigate the Pharmacokinetics and Safety of Fluticasone Furoate (FF)/ Umeclidinium (UMEC) Combination Compared With FF and UMEC Monotherapies in Adult Healthy Volunteers Using a Dry Powder Inhaler (DPI) [Phase 1]

See pricing